Michael D. Shafer net worth and biography

Michael Shafer Biography and Net Worth

Executive Vice President and President, Biopharma Services of Thermo Fisher Scientific

Mike became Executive Vice President and President, Biopharma Services in April 2024. In this role, he has responsibility for our Pharma Services and Clinical Research businesses. Prior to this role, Mike was Senior Vice President and President of our Pharma Services business since October 2019. He joined Thermo Fisher in 2009 as Vice President and General Manager of China and was named President of China in 2012. In 2015, Mike was appointed President of the Chemical Analysis business, and in 2016, following the acquisition of FEI Company, he became President, Materials and Structural Analysis.

Prior to joining Thermo Fisher, Mike worked at 3M Company for more than 15 years, managing various industrial and electronics businesses. With 3M, he spent seven years in the Asia-Pacific region, serving as APAC Business Director for the company’s Industrial & Transportation Businesses as well as APAC Electronics Market Materials Division Manager.

Mike earned his Bachelor of Arts degree from the University of Minnesota.

What is Michael D. Shafer's net worth?: The estimated net worth of Michael D. Shafer is at least $10.74 million as of November 25th, 2025. Mr. Shafer owns 18,731 shares of Thermo Fisher Scientific stock worth more than $10,736,516 as of December 4th. This net worth approximation does not reflect any other investments that Mr. Shafer may own. Learn More about Michael D. Shafer's net worth.
How do I contact Michael D. Shafer?: The corporate mailing address for Mr. Shafer and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Michael D. Shafer's contact information.
Has Michael D. Shafer been buying or selling shares of Thermo Fisher Scientific?: Over the course of the past ninety days, Michael D. Shafer has sold $6,435,000.00 in shares of Thermo Fisher Scientific stock. Most recently, Michael D. Shafer sold 10,725 shares of the business's stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $600.00, for a transaction totalling $6,435,000.00. Following the completion of the sale, the executive vice president now directly owns 18,731 shares of the company's stock, valued at $11,238,600. Learn More on Michael D. Shafer's trading history.
Who are Thermo Fisher Scientific's active insiders?: Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Lisa Britt (Senior Vice President and Chief Human Resources Officer), Marc Casper (Chairman, President & CEO), Joseph Holmes (VP & CAO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Frederick Lowery (Executive Vice President and President, Laboratory Products and BioProduction), Jim Manzi (Director), Gianluca Pettiti (EVP), Michael Shafer (Executive Vice President and President, Biopharma Services), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.
Are insiders buying or selling shares of Thermo Fisher Scientific?: During the last twelve months, insiders at the medical research company sold shares 23 times. They sold a total of 119,491 shares worth more than $65,374,961.64. The most recent insider tranaction occured on December, 2nd when EVP Frederick M Lowery sold 6,912 shares worth more than $4,022,369.28. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.
Information on this page was last updated on 12/2/2025.

Michael D. Shafer Insider Trading History at Thermo Fisher Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/25/2025	Sell	10,725	$600.00	$6,435,000.00	18,731

Michael D. Shafer Buying and Selling Activity at Thermo Fisher Scientific

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $574.76

$560.16

$580.45

50 Day Range

MA: $557.53

$461.95

$597.56

2 Week Range

Now: $574.76

$385.46

$610.97

Volume

1,961,632 shs

Average Volume

1,551,460 shs

Market Capitalization

$215.94 billion

P/E Ratio

33.20

Dividend Yield

0.30%

Beta

0.9